ArticleBMC infectious diseases2025
Incidence and risk factors of surgical site infection following cesarean section: a prospective cohort study at Jimma university medical center.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Onset of first symptoms and timing of clinician notification of surgical site infections following cesarean section: evidence from six tertiary hospitals in Nigeria.Infection prevention in practice · 2026Article
- Surgical site infection and associated factors among women who underwent cesarean delivery at Gandhi Memorial Hospital, Addis Ababa, Ethiopia.BMC pregnancy and childbirth · 2026Article
- Epidemiological patterns, risk factors, and prevention gaps of surgical site infections in operating rooms: a hospital-based surveillance study.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSurgical site infection (SSI) after cesarean section (CS) is one of the contributors for high maternal mortality and morbidity rates.
aimThis prospective cohort analysis assessed the incidence rate and risk factors of time to SSI following CS among women who were admitted to Jimma University Medical Center (JUMC).
methodData was gathered from CS patients who were admitted to the maternity ward at JUMC. The study included women who were admitted to the JUMC maternity ward, had CS, and agreed to participate. The study excluded women who died soon after or during the CS surgery. 417 of the 1,081 women who had CS throughout the study period fulfilled the criteria. We have used the Kaplan-Meir estimator and the Cox proportional hazard model for the analysis and model building.
resultsThe study included 417 women out of 1,081 who underwent CS between March and August 2022. The incidence rate for SSI following CS among women was 19.7%. The survival curve shows that the contaminated and dirty wound classification have significantly lower survival rates than other surgical wound classifications. The Cox proportional model result indicates; body mass index (BMI) (HR: 1.08, 95% CI: 1.01-1.15), time to give antibiotic prophylaxis (HR: 1.03, 95%CI: 1.01- 1.06), duration of operation (HR: 1.02, 95% CI: 1.01- 1.03), admission status (HR: 1.65, 95% CI: 1.05 -2.59), and duration of labor (HR: 1.04, 95% CI: 1.01- 1.08) (HR: 1.08, 95% CI: 1.01-1.15), time to give antibiotic prophylaxis (HR: 1.03, 95% CI: 1.01- 1.06), duration of operation (HR: 1.02, 95% CI: 1.01- 1.03), admission status (HR: 1.65, 95% CI: 1.05 -2.59), and duration of labor (HR: 1.04, 95% CI: 1.01- 1.08) covariates are significant at a 5% level of significance.
conclusionThe magnitude of SSI following CS is high. The duration of labor, BMI, procedure time, and the timing of treatment were risk factors of SSI after CS. Women with a high BMI and referring-admitted patients should also receive extra care. Therefore, strict treatment is required, along with close observation and follow-up. Finally, increased awareness of these risk factors, continuous training in infection prevention techniques may minimize and prevent the high SSI rate after CS. Furthermore, to effectively prevent surgical site infections (SSIs) in cesarean section (CS) patients, action-oriented measures such as strengthening antibiotic prophylactic guidelines and enhancing surveillance of vulnerable women are essential. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.